Official Journal Health Science of Prince of Songkla University

  • Home
  • Search
  • Current
  • Archives
  • Announcements
  • Guide for Authors
  • Publication Ethics
  • Editorial Board
  • Submit
  • About
  • Contact
  • Online-first Articles
  • EVENTS
  • Review Process
Home > Vol 42, No 4 (2024) > Thaidumrong

Surgical Experience and Results of Retzius Sparing Robotic Assisted Laparoscopic Radical Prostatectomy: First Report in Thailand

Tanet Thaidumrong, Sermsin Sindhubodee, Somjith Duangkae

Abstract

Objective: To evaluate the outcomes and safety of the surgical technique Retzius-sparing robot-assisted laparoscopic radical prostatectomy (RS-RALRP), with prostatic cancer; the first report in Thailand.
Material and Methods: The authors conducted a retrospective analysis from the medical records of 100 patients who underwent RS-RALRP by a single surgeon; from 1st January 2021 until 31st May 2023, at Rajavithi Hospital. The authors analyzed demographic data, clinical staging, Gleason grade group, operative time, pathologic staging, positive surgical margin rate; postoperative continence recovery and postoperative complications.
Results: The median age was 71.34±6.84 years: mean total PSA was 17.16±17.55 ng/ml; with the majority in clinical T1 and T2. The mean operative time was 221.7±51.93 minutes, and the mean estimated blood loss was 312.30±264.55 ml. Of all patients, 88% did not require blood transfusion. The complication rate was 8%. The pathologic stages pT2 and pT3 or greater were 62% and 38%, respectively. Positive surgical margins (PSM) pT2 and pT3 were 14.5% and 63.2%. The postoperative continence recovery after RS-RALRP were 83%, 95%, 97%,100% and 100%: at 1, 3, 6, 9 and 12 months postoperatively, respectively.
Conclusion: RS-RALRP has a potential to become the new standard for prostate cancer treatment, with improved early continence and equivalent oncologic efficacy. The limitations of this study are the small number of population, which require prospective multicenter studies.

 Keywords

prostate cancer; Retzius-sparing; robotic-assisted surgery; RS-RALRP; RS-RARP

 Full Text:

PDF

References

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.

Lojanapiwat B. Urologic cancer in Thailand. Jpn J Clin Oncol 2015;45:1007–15. doi: 10.1093/jjco/hyv125.

Chen J, Oromendia C, Halpern JA, Ballman KV. National trends in the management of localized prostate cancer: a populationbased analysis 2004-2013. Prostate 2018;78:512–20.

Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17.

Roth AJ, Weinberger MI, Nelson CJ. Prostate cancer: quality of life, psychosocial implications and treatment choices. Future Oncol 2008:561–68. doi: 10.2217/14796694.4.4.561.

Umari P, Eden C, Cahill D, Rizzo M, Eden D, Sooriakumaran P. Retzius-sparing versus standard robot-assisted radical prostatectomy: a comparative prospective study of nearly 500 patients. J Urol 2021;205:780-90. doi: 10.1097/JU.0000000000001435.

Lee J, Kim HY, Goh HJ, Heo JE, Almujalhem A, Alqahtani AA, et al. Retzius sparing robot-assisted radical prostatectomy conveys early regain of continence over conventional robotassisted radical prostatectomy: a propensity score matched analysis of 1,863 patients. J Urol 2020;203:137-44. doi: 10.1097/JU.0000000000000461.

Galfano A, Di Trapani D, Sozzi F, Strada E, Petralia G, Bramerio M, et al. Beyond the learning curve of the Retzius-sparing approach for robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of the first 200 patients with ≥1 year of follow-up. Eur Urol 2013;64:974-80.

Chang LW, Hung SC, Hu JC, Chiu KY. Retzius-sparing roboticassisted radical prostatectomy associated with less bladder neck descent and better early continence outcome. Anticancer Res 2018;38:345-51. doi: 10.21873/anticanres.12228.

Dalela D, Jeong W, Prasad MA, Sood A, Abdollah F, Diaz M, et al. A pragmatic randomized controlled trial examining the impact of the Retzius-sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2017;72:677–85.

Xu JN, Xu ZY, Yin HM. Comparison of Retzius-sparing robotassisted radical prostatectomy vs. conventional robot-assisted radical prostatectomy: an up-to-date meta-analysis. Front Surg 2021;8:738421. doi: 10.3389/fsurg.2021.738421.

Sayyid RK, Simpson WG, Lu C et al. Retzius sparing roboticassisted laparoscopic radical prostatectomy: a safe surgical technique with superior continence outcomes. J Endourol 2017;31:1244-50.

Barakat B, Othman H, Gauger U, Wolff I, Hadaschik B, Rehme C. Retzius sparing radical prostatectomy versus robot-assisted radical prostatectomy: which technique is more beneficial for prostate cancer patients (master study)? a systematic review and meta-analysis. Eur Urol Focus 20228:1060-71. doi: 10.1016/j.euf.2021.08.003.

Menon M, Dalela D, Jamil M, Diaz M, Tallman C, Abdollah F, et al. Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the Retzius sparing and standard approaches. J Urol 2018;199:1210–7.

Egan J, Marhamati S, Carvalho FLF, Davis M, O'Neill J, Lee H, et al. Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise of oncologic efficacy: single surgeon series and step-by-step. Eur Urol 2021;79:839-57. doi: 10.1016/j.eururo.2020.05.010.

DOI: http://dx.doi.org/10.31584/jhsmr.20241040

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SUBMIT A PAPER

JHSMR accepts online submission through

AHR-iCON 2024

Journal Metrics


2020
Acceptance rate: 52%
2021
Acceptance rate: 27.8%
2022 (March)
Acceptance rate: 15.6%
2023 (June)
Acceptance rate: 23.6%
2024 (June)
Acceptance rate: 19%


Submission to final decision
74 days

Acceptance to publication
40 days

SCImago Journal & Country Rank

About The Authors

Tanet Thaidumrong
Minimally Invasive Surgery-Urology Rajavithi, Division of Urology, Department of Surgery, Rajavithi Hospital, College of Medicine, Rangsit University, Ratchathewi, Bangkok 10400,
Thailand

Sermsin Sindhubodee
Minimally Invasive Surgery-Urology Rajavithi, Division of Urology, Department of Surgery, Rajavithi Hospital, College of Medicine, Rangsit University, Ratchathewi, Bangkok 10400,
Thailand

Somjith Duangkae
Minimally Invasive Surgery-Urology Rajavithi, Division of Urology, Department of Surgery, Rajavithi Hospital, College of Medicine, Rangsit University, Ratchathewi, Bangkok 10400,
Thailand

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

Supported by

 

JHSMR now Indexed in



Scopus logo.svg






Image result for crossref





PSUMJ Homepage

Keywords COVID-19 SARS-CoV-2 Thailand anxiety children computed tomography depression diabetes diabetes mellitus elderly hypertension knowledge mental health mortality prevalence quality of life reliability risk factor risk factors treatment validity
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size

Open Journal Systems